|
|
|
Insider
Information: |
Hbm Bioventures Cayman Ltd |
Relationship: |
10% Owner |
City: |
Grand Cayman |
State: |
E9 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
28,058,903 |
|
Indirect Shares
|
1,435,154 |
|
|
Direct
Value |
$315,215,152 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
29,494,057 |
|
|
Total
Value |
$315,215,152 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Icagen Inc |
ICGN |
10% Owner |
2005-02-08 |
1,200,000 |
2005-02-08 |
0 |
Premium* |
|
Harbor Brewing Company Inc |
HBWOD |
10% Owner |
2005-03-16 |
3,964,615 |
2005-03-16 |
1,435,154 |
Premium* |
|
Micrus Endovascular Corp |
MEND |
10% Owner |
2010-02-24 |
1,681,599 |
2005-06-21 |
0 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
10% Owner |
2013-03-25 |
2,233,993 |
|
0 |
Premium* |
|
PTC Therapeutics, Inc. |
PTCT |
10% Owner |
2013-12-17 |
2,441,504 |
2013-06-25 |
0 |
Premium* |
|
Iveric Bio Inc |
ISEE |
10% Owner |
2014-05-13 |
3,139,902 |
2013-09-30 |
0 |
Premium* |
|
Apollo Endosurgery, Inc |
APEN |
10% Owner |
2014-09-26 |
2,780,836 |
|
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2015-05-29 |
1,747,680 |
|
0 |
Premium* |
|
Nabriva Therapeutics AG |
NBRV |
10% Owner |
2017-09-14 |
2,334,128 |
|
0 |
Premium* |
|
Werewolf Therapeutics, Inc. |
HOWL |
10% Owner |
2021-05-04 |
625,995 |
2021-05-04 |
0 |
Premium* |
|
Io Biotech, Inc. |
IOBT |
10% Owner |
2021-11-09 |
2,690,545 |
2021-11-09 |
0 |
Premium* |
|
Mineralys Therapeutics, Inc. |
MLYS |
10% Owner |
2023-02-14 |
3,218,106 |
2023-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-07-28 |
4 |
S |
$10.51 |
$69,195 |
D/D |
(6,585) |
2,391,177 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-06-29 |
4 |
S |
$10.72 |
$17,189 |
D/D |
(1,603) |
2,585,004 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-10 |
4/A |
S |
$10.73 |
$406,451 |
D/D |
(37,876) |
2,669,286 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-10 |
4 |
S |
$10.73 |
$406,451 |
D/D |
(37,876) |
185,394 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2009-08-07 |
4 |
S |
$10.80 |
$273,625 |
D/D |
(25,000) |
1,960,739 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-06-27 |
4 |
S |
$10.83 |
$23,457 |
D/D |
(2,166) |
2,591,396 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2009-08-11 |
4 |
S |
$10.88 |
$479,461 |
D/D |
(43,900) |
1,893,539 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-06-30 |
4 |
S |
$10.94 |
$19,420 |
D/D |
(1,775) |
2,583,229 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-07-03 |
4 |
S |
$10.95 |
$124,250 |
D/D |
(11,352) |
2,571,877 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-07 |
4/A |
S |
$10.96 |
$235,931 |
D/D |
(21,501) |
2,707,162 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-07 |
4 |
S |
$10.96 |
$235,931 |
D/D |
(21,501) |
223,270 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2009-08-10 |
4 |
S |
$11.00 |
$232,863 |
D/D |
(21,100) |
1,939,639 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2009-08-12 |
4 |
S |
$11.00 |
$551,610 |
D/D |
(50,000) |
1,843,539 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-20 |
4 |
S |
$11.00 |
$3,575 |
D/D |
(325) |
2,612,523 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-26 |
4 |
S |
$11.00 |
$7,799 |
D/D |
(709) |
2,609,192 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-27 |
4 |
S |
$11.00 |
$1,100 |
D/D |
(100) |
2,609,092 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-28 |
4 |
S |
$11.03 |
$166,813 |
D/D |
(15,130) |
2,593,962 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-21 |
4 |
S |
$11.04 |
$28,937 |
D/D |
(2,622) |
2,609,901 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-19 |
4 |
S |
$11.07 |
$130,434 |
D/D |
(11,785) |
2,612,848 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-06-28 |
4 |
S |
$11.10 |
$53,158 |
D/D |
(4,789) |
2,586,697 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-13 |
4 |
S |
$11.13 |
$122,232 |
D/D |
(10,984) |
2,636,455 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-18 |
4 |
S |
$11.16 |
$131,880 |
D/D |
(11,822) |
2,624,633 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2009-08-10 |
4 |
S |
$11.18 |
$24,655 |
D/D |
(2,200) |
1,937,439 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-06 |
4/A |
S |
$11.20 |
$350,160 |
D/D |
(31,217) |
2,728,663 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-06 |
4 |
S |
$11.20 |
$350,160 |
D/D |
(31,217) |
244,771 |
0 |
- |
|
104 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|